Comprehensive management of paranasal sinus fungus balls: A Young-IFOS consensus statement.
Alberto Maria SaibeneFabiana AlleviChristian Calvo-HenríquezNicolas DaubyDaniele DondossolaRémi HervochonJérome R LechienDavid Lobo-DuroLuca Giovanni LocatelloAntonino ManiaciGiuditta MannelliMiguel Mayo YanezJuan Maza-SolanoThomas RadulescoNeil TanCamilla TincatiManuel TucciaroneLuigi Angelo VairaLeigh J SowerbyPublished in: International forum of allergy & rhinology (2022)
Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment.
Keyphrases
- magnetic resonance imaging
- computed tomography
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- magnetic resonance
- high resolution
- contrast enhanced
- positron emission tomography
- patient reported outcomes
- big data
- electronic health record
- artificial intelligence
- small bowel
- replacement therapy
- clinical evaluation